a public good project by the
Synthesis
Company
of California

© 2026

Dalin He | doi.page

0 works0 citations0 h-index

Dalin He

Sichuan University(CN)State Key Laboratory of Oral Diseases

Publications by Year

Research Areas

Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Cancer, Hypoxia, and Metabolism, Bladder and Urothelial Cancer Treatments, Cancer, Lipids, and Metabolism

Most-Cited Works

→ Role of Wnt/β‐catenin signaling pathway in epithelial‐mesenchymal transition of human prostate cancer induced by hypoxia‐inducible factor‐1α(2007)218 cited
→ Prostate cancer in Asia: A collaborative report(2014)208 cited
→ Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4(2012)180 cited
→ Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019(2021)167 cited
→ Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3(2016)126 cited
→ Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling(2015)120 cited

→ Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness(2013)

117 cited

→ Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog–Gli1 pathway(2012)117 cited

→ Knockdown of β-Catenin Through shRNA Cause a Reversal of EMT and Metastatic Phenotypes Induced by HIF-1α(2011)116 cited

→ Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression(2009)107 cited